{"id":379,"date":"2026-07-01T08:43:40","date_gmt":"2026-07-01T08:43:40","guid":{"rendered":"https:\/\/injectionstretchblowmolding.com\/?p=379"},"modified":"2026-07-01T08:43:40","modified_gmt":"2026-07-01T08:43:40","slug":"injection-blow-molding-for-pharmaceutical-bottles-fda-compliance-gmp-and-best-practices","status":"publish","type":"post","link":"https:\/\/injectionstretchblowmolding.com\/ru\/application\/injection-blow-molding-for-pharmaceutical-bottles-fda-compliance-gmp-and-best-practices\/","title":{"rendered":"Injection Blow Molding for Pharmaceutical Bottles: FDA Compliance, GMP and Best Practices"},"content":{"rendered":"
\n
\n

Why Injection Blow Molding Dominates Pharmaceutical Container Production — and What FDA, GMP, and Pharmacopoeial Standards Require of the Machine, the Resin, and the Production Environment<\/h2>\n

Pharmaceutical packaging is not ordinary packaging. Every container that touches a drug product — whether it holds an oral liquid, a tablet, a topical cream, or an eye drop — is a component of the finished drug product under FDA, EMA, and equivalent regulatory frameworks worldwide. The container must not interact with the drug product, must not leach extractables or leachables that affect patient safety, must maintain the product’s stability throughout its shelf life, and must be produced in an environment that prevents contamination.<\/p>\n

Injection blow molding has earned its position as the dominant container production process for pharmaceutical packaging through a combination of properties that no competing process fully replicates: flash-free production that eliminates trim-waste contamination risk, injection-quality neck thread precision for reliable closure engagement, excellent dimensional consistency cycle to cycle, and — in all-electric machine configurations — complete elimination of hydraulic oil contamination risk. This guide explains the regulatory framework that governs pharmaceutical IBM container production, the specific technical requirements it imposes, and the best practices that define a compliant pharmaceutical IBM operation.<\/p>\n<\/header>\n

<\/p>\n